Design and evaluation of self‑nanoemulsifying drug delivery systems for nebivolol hydrochloride

Main Article Content

Rahul Shankar Narkhede
Kishor N. Gujar
Vaishali Makarand Gambhire


Nebivolol hydrochloride (NEB) is third generation beta‑blocker, approved by the FDA to treat a hypertension. It’s a
racemic mixture of a d‑Nebivolol and l‑Nebivolol. Oral delivery of the NEB shows a lower bioavailability due to its poor
solubility and permeability. In present study, self nano emulsifying drug delivery is formulated to increase the bioavailability
of drug by increasing solubility and permeability through the gastro intestinal membrane. Excipients are selected on basis
of results obtained from solubility studies of drug in various surfactants and oils. Selected system of oil, surfactant and
co‑surfactant were screened for their miscibility and emulsification ability. The ternary phase diagram was constructed using
system Capmul MCM EP as oil, Tween‑60 as surfactant, Transcutol HP and PEG‑400 as co‑surfactant. Five compositions
were prepared from the self‑emulsifying area of the ternary diagram, loaded with NEB and then tested for robustness to
dilution, pH effect on globule size, mean globule size and polydispersity index (PDI), zeta potential, viscosity and drug
release for the selection of optimized formulation. Further, the effect of viscosity and pH on the globule size and PDI of
optimized SNEDDS was studied. In‑vitro drug release study was performed using dialysis bag method. Ex‑vivo drug release
studies were also carried out to determine the permeability of drug loaded SNEDDS through the stomach and intestinal
membrane. The optimum concentration of a system determined Capmul MCM EP 25%, Tween‑60 50%, Transcutol HP
12.5%, PEG‑400 12.5% with a globule size of 124.5 nm, cloud point at 770C and zeta potential of ‑5.123 mV. In‑vitro drug
release study and ex‑vivo permeation study showed significant increase in dissolution rate and permeability respectively, as
compared to the drug suspension and marketed preparation (NEBISTARâ„¢).
Key words: Dissolution, ex‑vivo drug release, nebivolol hydrochloride, self‑nanoemulsifying drug delivery systems, solubility studies


Download data is not yet available.

Article Details

How to Cite
Narkhede, R. S., Gujar, K. N., & Gambhire, V. M. (2014). Design and evaluation of self‑nanoemulsifying drug delivery systems for nebivolol hydrochloride. Asian Journal of Pharmaceutics (AJP), 8(3).


Robinson JR. Introduction: Semi‑solid formulations for oral drug

delivery. Bull Tech Gattefosse1996;89:11‑3.

Venkatesh S, Li J, Xu Y, Vishnuvajjala R, Anderson BD. Intrinsic solubility

estimation and pH‑solubility behavior of cosalane (NSC 658586), an

extremely hydrophobic diprotic acid. Pharm. Res. 1996;13:1453‑9.

Seedher N, Bhatia S. Solubility enhancement of Cox‑2 inhibitors using

various solvent systems. AAPS PharmSciTech 2003;4:E33.

Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I A

comparison of the behavior of eutectic mixture of sulfathiazole and

that of ordinary sulfathiazole in man. Chem Pharm Bull 1961;9:866‑2.

Tiwari R, Tiwari G, Srivastava B, Rai AK. Solid dispersions: An overview

to modify bioavailability of poorly water soluble drugs. Int J PharmTech

Res 2009;1:1338‑49.

Leuner C, Dressman J. Improving drug solubility for oral delivery using

solid dispersions. Eur J Pharm Biopharm 2000;50:47‑60.

Badwana AA, Khordaguib LK, Saleh AM, Khalil SA. The solubility

of benzodiazepines in sodium salicylate solution and a proposed

mechanism for hydrotropic solubilization. Int J Pharm 1982;13:67‑74.

Torchilin VP. Structure and design of polymeric surfactant‑based drug

delivery systems. J Control Release 2001;73:137‑72.

Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins.

Drug solubilization and stabilization. J Pharm Sci 1996;85:1017‑25.

Burcham DL, Maurin MB, Hausner EA, Huang SM. Improved oral

bioavailability of the hypocholesterolemic DMP 565 in dogs following

oral dosing in oil and glycol solutions. Biopharm Drug Dispos


Ghosh PK, Murthy RS. Microemulsions: A potential drug delivery system.

Curr Drug Deliv 2006;3:167‑80.

Gursoy RN, Benita S. Self‑emulsifying drug delivery systems (SEDDS)

for improved oral delivery of lipophilic drugs. Biomed Pharmacother


Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug

solubilisation using lipid‑based delivery systems. Adv Drug Deliv Rev


Mou D, Chen H, Du D, Mao C, Wan J, Xu H, et al. Hydrogel‑thickened

nanoemulsion system for topical delivery of lipophilic drugs. Int J Pharm


Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self‑emulsifying

drug delivery systems (SEDDS) with polyglycolysed glycerides for

improving in vitro dissolution and oral absorption of lipophilic drugs.

Int J Pharm 1994;106:15‑23.

Constantinides PP. Lipid microemulsions for improving drug dissolution

and oral absorption: Physical and biopharmaceutical aspects. Pharm

Res 1995;12:1561‑72.

Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid‑based

formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev

Drug Discov 2007;6:231‑48.

Singh B, Bandopadhyay S, Kapil R, Singh R, Katare O. Self‑emulsifying drug

delivery systems (SEDDS): Formulation development, characterization,

and applications. Crit Rev Ther Drug Carrier Syst 2009;26:427‑51.

Charman WN. Lipids, lipophilic drugs, and oral drug delivery‑some

emerging concepts. J Pharm Sci 2000;89:967‑78.

Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ,

Pouton CW. Self‑emulsifying drug delivery systems: Formulation and

biopharmaceutic evaluation of an investigational lipophilic compound.

Pharm Res 1992;9:87‑93.

Eccleston J. Microemulsions. In: Swarbrick J, Boylan JC, editors.

Encyclopedia of Pharmaceutical Technology. Vol. 9. New York: Marcel

Dekker; 1994. p. 375‑421.

Lawrence MJ, Rees GD. Microemulsion‑based media as novel drug

delivery systems. Adv Drug Deliv Rev 2000;45:89‑121.

Cuiné JF, McEvoy CL, Charman WN, Pouton CW, Edwards GA,

Benameur H, et al. Evaluation of the impact of surfactant digestion

on the bioavailability of danazol after oral administration of lipidic

self‑emulsifying formulations to dogs. J Pharm Sci 2008;97:995‑1012.

Rane SS, Anderson BD. What determines drug solubility in lipid vehicles:

Is it predictable? Adv Drug Deliv Rev 2008;60:638‑56.

Wasan EK, Bartlett K, Gershkovich P, Sivak O, Banno B, Wong Z, et al.

Development and characterization of oral lipid‑based amphotericin B

formulations with enhanced drug solubility, stability and antifungal

activity in rats infected with Aspergillus fumigatus or Candida albicans.

Int J Pharm 2009;372:76‑84.

Shen H, Zhong M. Preparation and evaluation of self‑microemulsifying

drug delivery systems (SMEDDS) containing atorvastatin. J Pharm

Pharmacol 2006;58:1183‑91.

Kommuru TR, Gurley B, Khan MA, Reddy IK. Self‑emulsifying drug

delivery systems (SEDDS) of coenzyme Q10: Formulation development

and bioavailability assessment. Int J Pharm 2001;212:233‑46.

Tang B, Cheng G, Gu JC, Xu CH. Development of solid self‑emulsifying

drug delivery systems: Preparation techniques and dosage forms. Drug

Discov Today 2008;13:606‑12.

Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of a

new self‑nanoemulsifying drug delivery system. J Colloid Interface Sci


Halbaut L, Barbé C, Del Pozo A. An investigation into physical and

chemical properties of semi‑solid self‑emulsifying systems for hard

gelatin capsules. Int J Pharm 1996;2:203‑12.

Abdalla A, Klein S, Mäder K. A new self‑emulsifying drug delivery

system (SEDDS) for poorly soluble drugs: Characterization, dissolution,

in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci


Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of

solid self‑emulsifying systems in the delivery of diclofenac. Int J Pharm


Available from:

html. [Accessed on 2011 Sep 21].

St. Louis MO: Forest Laboratories, Inc.; 2007. Bystolic (nebivolol),

package insert.

Prisant LM. Nebivolol: Pharmacologic profile of an ultraselective,

vasodilatory beta1‑blocker. J Clin Pharmacol 2008;48:225‑39.

Moen MD, Wagstaff AJ. Nebivolol: A review of its use in the management

of hypertension and chronic heart failure. Drugs 2006;66:1389‑409.

Weiss R. Nebivolol: A novel beta‑blocker with nitric oxide‑induced

vasodilatation. Vasc Health Risk Manag 2006;2:303‑8.

Parmar N, Singla N, Amin S, Kohli K. Study of cosurfactant effect

on nanoemulsifying area and development of lercanidipine

loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids

Surf B Biointerfaces 2011;86:327‑38.

Gupta S, Chavhan S, Sawant K. Self‑nanoemulsifying drug delivery

system for adefovir dipivoxil: Design, characterization, in‑vitro

and ex‑vivo evaluation. Colloids Surf A Physicochem Eng Asp


Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation

of self‑nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech


Elnaggar YS, El‑Massik MA, Abdallah OY. Self‑nanoemulsifying drug

delivery systems of tamoxifen citrate: Design and optimization. Int J

Pharm 2009;380:133‑41.

Singh B, Singh R, Bandyopadhyay S, Kapil R, Garg B. Optimized

nanoemulsifying systems with enhanced bioavailability of carvedilol.

Colloids Surf B Biointerfaces 2013;101:465‑74.

Georgakopoulos E, Farah N, Vergnault G. Oral anhydrous non-ionic

nanoemulsions administered in soft gel capsules. B.T. Gattefosse


Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying

drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm


Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, et al.

Nanoemulsion components screening and selection: A technical note.

AAPS PharmSciTech 2009;10:69-76.

Cirri M, Mura P, Mora PC. Liquid spray formulations of xibornol by using

self-microemulsifying drug delivery systems. Int J Pharm 2007;340:84-91.

Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of selfmicroemulsifying

drug delivery system of oridonin. Int J Pharm


Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation and in

vitro characterization of a eutectic based semisolid self-nanoemulsified

drug delivery system (SNEDDS) of ubiquinone: Mechanism and progress

of emulsion formation. Int J Pharm 2002;235:247-65.

Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane

transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002;16:237-46.

Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for

oral administration: Materials, methods and strategies. Adv Drug Deliv

Rev 2008;60:625-37.

Spernath A, Aserin A. Microemulsions as carriers for drugs and

nutraceuticals. Adv Colloid Interface Sci 2006;128-130:47-64.

Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporine

in rats through the reduction of emulsion droplet size. Pharm Res


Gershanik T, Haltner E, Lehr CM, Benita S. Charge-dependent interaction

of self-emulsifying oil formulations with Caco-2 cells monolayers:

Binding, effects on barrier function and cytotoxicity. Int J Pharm


Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, et al. Development

of self-microemulsifying drug delivery systems (SMEDDS) for oral

bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm


Pouton CW. Lipid formulations for oral administration of drugs: Nonemulsifying,

self-emulsifying and 'self-microemulsifying' drug delivery

systems. Eur J Pharm Sci 2000;11 Suppl 2:S93-8.

Jose S, Kulkarni PK. Self emulsifying drug delivery systems (SEDDS): A

review. Indian J Pharm Educ 2002;36:1-7.

O'Driscoll CM. Lipid-based formulations for intestinal lymphatic

delivery. Eur J Pharm Sci 2002;15:405-15.

Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral

absorption of lipophilic drugs. Eur J Pharm Biopharm 2000;50:179-88.

Woo JS, Kim TS, Park JH, Chi SC. Formulation and biopharmaceutical

evaluation of silymarin using SMEDDS. Arch Pharm Res 2007;30:82-9.

Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation

design of self-microemulsifying drug delivery systems for improved

oral bioavailability of celecoxib. Biol Pharm Bull 2004;27:1993-9.

Wei L, Sun P, Nie S, Pan W. Preparation and evaluation of SEDDS and

SMEDDS containing carvedilol. Drug Dev Ind Pharm 2005;31:785-94.

Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin AT. Effect of

combined use of nonionic surfactant on formation of oil-in-water

microemulsions. Int J Pharm 2005;288:27-34.

Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for

oral delivery of simvastatin: In vitro and in vivo evaluation. Acta Pharm


Constantinides PP, Scalart JP. Formulation and physical characterization

of water-in-oil microemulsions containing long-versus medium-chain

glycerides. Int J Pharm 1997;158:57.

Patil PR, Biradar SV, Paradkar AR. Extended release felodipine selfnanoemulsifying

system. AAPS Pharm Sci Tech 2009;10:515-23.

Kim JY, Ku YS. Enhanced absorption of indomethacin after oral or rectal

administration of a self-emulsifying system containing indomethacin

to rats. Int J Pharm 2000;194:81-9.

Itoh K, Tozuka Y, Oguchi T, Yamamoto K. Improvement of physicochemical

properties of N-4472 part I formulation design by using selfmicroemulsifying

system. Int J Pharm 2002;238:153-60.

Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M.

Development and bioavailability assessment of ramipril nanoemulsion

formulation. Eur J Pharm Biopharm 2007;66:227-43.

Nielsen FS, Petersen KB, Müllertz A. Bioavailability of probucol from

lipid and surfactant based formulations in minipigs: Influence of droplet

size and dietary state. Eur J Pharm Biopharm 2008;69:553-62.